Smurf2 Regulates DNA Repair and Packaging to Prevent Tumors
Following DNA damage, Smurf2, labeled in green, moves to sites of double-stranded DNA breaks, shown in red. Because Smurf2 regulates a cell’s response to DNA damage at these sites as well as the organization of the DNA in the nucleus, loss of Smurf2 may promote tumor formation.
The blueprint for all of a cell’s functions is written in the genetic code of DNA sequences as well as in the landscape of DNA and histone modifications. DNA is wrapped around histones to package it into chromatin, which is stored in the nucleus. It is important to maintain the integrity of the chromatin structure to ensure that the cell continues to behave appropriately. Recently, Ying Zhang, Ph.D., Senior Investigator in CCR’s Laboratory of Cellular and Molecular Biology, and her colleagues showed that alterations in the organization of the DNA can lead to tumor growth in a variety of tissues. This study appeared in the February 2012 issue of Nature Medicine and was featured as a cover story of that issue.
To understand how cancer cells might acquire changes in the chromatin landscape, Michael Blank, Ph.D., a Postdoctoral Fellow in Dr. Zhang’s lab investigated the role of the protein Smurf2. Numerous previous studies have demonstrated that Smurf2 functions as an enzyme that adds a tag, called ubiquitin, to proteins to signal their destruction, but there is only scant information about whether Smurf2 has any role in cancer.
The researchers generated a mouse model in which they prevented Smurf2 expression
(Smurf2-/-). Smurf2-/- mice develop normally and have no obvious physical problems early on. However, tumors begin to grow in a variety of tissues as the mice age, suggesting that Smurf2 may play a role in preventing tumor formation.
To determine how Smurf2 might inhibit tumors, the researchers studied cells from normal mice and from Smurf2-/- mice. Initially, the cells grew at the same rate, but over time, the Smurf2-/- cells began to grow faster and expressed genes distinct from the normal cells. Smurf2-/- cells also formed tumors when injected into mice. Re-expressing Smurf2 in the Smurf2-/- cells did not correct their altered growth and indicated that changes in the cells’ DNA may have already occurred.
The researchers wondered whether Smurf2 might play a role in protecting a cell’s DNA. Treatment with a DNA-damaging agent caused a stronger response in the Smurf2-/- cells, but more of the cells were able to survive even in the presence of unrepaired DNA. In normal cells treated with the DNA-damaging agent, Smurf2 actually localized to sites of DNA damage. Smurf2-/- cells that were cultured longer had less compact DNA and more altered chromosomes than normal cells. Together these observations indicate that Smurf2 plays a role in regulating the DNA damage response and the packaging of DNA.
Chromosomes are made up of DNA wound around histone proteins, and the addition of certain molecules to histones allows DNA to wrap more or less tightly around these proteins. The researchers found that certain histone modifications were increased in Smurf2-/- cells. Levels of another protein called RNF20, which makes one of these histone modifications, were also increased in Smurf2-/- cells, but there was no difference in expression of the RNF20 gene. Instead, the investigators found that Smurf2 can directly target RNF20 for destruction by adding ubiquitin. Decreasing the levels of RNF20 in Smurf2-/- cells decreased the histone modification, increased DNA packaging, and decreased cell growth. Expressing RNF20 in normal cells, on the other hand, increased their growth rate. The researchers also found that Smurf2 and RNF20 move to sites of DNA damage where Smurf2 decreases the level of RNF20. These results show that Smurf2 plays an important role in tumor formation in the mouse by regulating RNF20, which controls the DNA damage response and DNA packaging. But is the same pathway important in human tumors?
To address this question, the researchers examined a number of human tumor cell lines. Similar to mouse cells, they found that removing Smurf2 resulted in increased RNF20 levels and its associated histone modification, while loss of RNF20 increased DNA packaging. In a panel of 40 breast tumors, the investigators found that 32 tumors (80 percent) expressed high levels of RNF20 protein. A set of 55 lymphomas showed similar elevated levels of RNF20.
This research has shown that human DNA is sensitive to the levels of Smurf2 and RNF20 and that loss of Smurf2 function may contribute to human tumor formation via changes in the DNA damage response and chromosomal organization. Future studies will need to investigate whether inhibiting RNF20 activity or reactivating Smurf2 can prevent tumor formation in human cells.
Summary Posted: 6/2012
Blank M, Tang Y, Yamashita M, Burkett SS, Cheng SY, Zhang YE. A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20. Nat. Med. 2012 February. PubMed Link
Note: All questions should be directed to TellCCR
- Changes in Bacteria Induce Inflammatory Skin Diseases
- Synthetic Spores Give Insight into the Real Thing and Reveal Functional Applications
- Splicing Modulation as a Potential Treatment for Vemurafenib-Resistant Melanoma
- Hepatic Stellate Cells Alter Liver Immune Environment to Promote Cancer
- Adoptive T-cell Therapy Promising for Metastatic Cervical Cancer
- Stop Stalling: Mus81 Required for Efficient Replication
- Mig6 Puts the Brakes on Mutant EGFR-Driven Lung Cancer
- Immunotoxin Targeting Glypican-3 Effective against Liver Tumors
- Identifying a New Mechanism of HIV Core Formation
- p53 Regulates Bone Differentiation and Osteosarcoma Formation
- Small RNA Enhances Antitumor T-cell Therapy
- First-in-Human Study of Interleukin-15 as Immunotherapy for Metastatic Cancer
- Drosophila TDP1 Ortholog Important for Longevity and Nervous System Maintenance
- CAR T Cell Immunotherapy Promising in Refractory Leukemia